Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging | Zendy

Manuel D. Cerqueira | Zendy; Patricia K. Nguyen | Zendy; Peter Staehr | Zendy; S. Richard Underwood | Zendy; Ami E. Iskandrian | Zendy

Open Access

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging

Author(s) -

Manuel D. Cerqueira,

Patricia K. Nguyen,

Peter Staehr,

S. Richard Underwood,

Ami E. Iskandrian

Publication year - 2008

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2008.02.003

Subject(s) - regadenoson , medicine , myocardial perfusion imaging , adenosine , anesthesia , bolus (digestion) , cardiology , diabetes mellitus , perfusion , endocrinology

To compare the effects of age, gender, body mass index, and diabetes on the safety and efficacy of regadenoson stress myocardial perfusion imaging, and to assess the noninferiority of regadenoson to adenosine for the detection of reversible myocardial perfusion defects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research